secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ultragenyx Pharmaceutical Inc. (RARE)
CIK:        0001515673
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0000950170-23-047138
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultragenyx moves CFO start date to Oct 9 from Oct 16, 2023
----------------------------------------------------------

- Howard Horn's appointment as CFO & EVP, Corporate Strategy effective October 9, 2023, one week earlier than originally announced.
- Amendment No. 1 to offer letter dated September 6, 2023 changes only the start date; all other terms unchanged.
- Original effective date of October 16, 2023 was disclosed in the July 12, 2023 Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1515673/000095017023047138/0000950170-23-047138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1515673/000095017023047138/rare-20230906.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-047138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer